Pay-For-Delay Ban Dropped From Health Care Bill
Congress has elected to leave out a proposed ban on "pay-for-delay" settlements between generic and brand-name drugmakers from its health care reform package, a policy idea beloved by consumer advocates but...To view the full article, register now.
Already a subscriber? Click here to view full article